Laboratory of America Holdings (LH)
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US50540R4092
Laboratory Corporation of America Holdings, trading under NYSE symbol LH, functions as a leading life sciences corporation that plays a crucial role in assisting medical professionals, hospitals, pharmaceutical firms, researchers, and patients in making well-informed decisions. The company operates through two key segments, namely Labcorp Diagnostics and Labcorp Drug Development.
Labcorp offers a wide range of tests including blood chemistry analyses, urinalyses, thyroid tests, PAP tests, vitamin D assessments, tests for sexually transmitted diseases, microbiology cultures, hepatitis C screenings, among many others. Additionally, they specialize in gene-based testing, esoteric testing, and disease-specific evaluations encompassing areas such as oncology, cardiology, genetics, infectious diseases, and women's health.
Moreover, Labcorp provides a variety of health and wellness services to employers and managed care organizations, including health fairs, on-site testing, vaccinations, and health screenings. The company also offers online and mobile applications for patients to access their test results conveniently and efficiently.
Furthermore, Labcorp delivers end-to-end solutions in drug development, medical device pioneering, and companion diagnostic development, catering to early-stage research through clinical development and commercial market access. Their clientele includes managed care organizations, pharmaceutical companies, medical device manufacturers, healthcare providers, employers, patients, and clinical laboratories.
Established in 1994, Labcorp's headquarters are located in Burlington, North Carolina. For more information, visit their website at https://www.labcorp.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
LH Stock Overview
Market Cap in USD | 17,935m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Health Care Services |
TER | 0.00% |
IPO / Inception | 1990-03-29 |
LH Stock Ratings
Fundamental | 1.64 |
Dividend | 1.87 |
Growth 5y | 4.78 |
Rel. Performance vs Sector | -0.15 |
Analysts | 4.06/5 |
Fair Price Momentum | 200.15 USD |
Fair Price DCF | 279.99 USD |
LH Dividends
Yield 12m | 1.28% |
Yield on Cost 5y | 2.14% |
Dividends CAGR 5y | 4.02% |
Payout Consistency | 7.4% |
LH Growth Ratios
Growth 12m | 15.18% |
Growth Correlation 12m | 53% |
Growth Correlation 3m | -64% |
CAGR 5y | 10.78% |
Sharpe Ratio 12m | 0.56 |
Alpha vs SP500 12m | -16.21 |
Beta vs SP500 5y weekly | 0.97 |
ValueRay RSI | 57.77 |
Volatility GJR Garch 1y | 20.91% |
Price / SMA 50 | -1.03% |
Price / SMA 200 | 2.32% |
Current Volume | 430.7k |
Average Volume 20d | 787.2k |
External Links for LH Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of March 29, 2024, the stock is trading at USD 216.57 with a total of 430,701 shares traded.
Over the past week, the price has changed by +3.44%, over one month by +0.41%, over three months by -4.14% and over the past year by +16.25%.
According to ValueRays Forecast Model, LH Laboratory of America Holdings will be worth about 219.8 in March 2025. The stock is currently trading at 216.57. This means that the stock has a potential upside of +1.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 246.8 | 14.0% |
Analysts Target Price | 244.1 | 12.7% |
ValueRay Target Price | 219.8 | 1.51% |